tyrosine and incb-018424

tyrosine has been researched along with incb-018424 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hosoi, H; Imamura, T; Kanayama, T; Kato, I; Kawamura, M; Mayumi, A; Mikami, T; Nakahata, T; Takita, J; Tanaka, K; Tomii, T; Ueno, H; Yoshida, H	1

Other Studies

1 other study(ies) available for tyrosine and incb-018424

Article	Year
The combination of ruxolitinib and Bcl-2/Mcl-1 inhibitors has a synergistic effect on leukemic cells carrying a SPAG9::JAK2 fusion. Cancer gene therapy, 2022, Volume: 29, Issue:12 Topics: Adaptor Proteins, Signal Transducing; Child; Humans; Interleukin-3; Janus Kinase 2; Myeloid Cell Leukemia Sequence 1 Protein; Oncogene Proteins, Fusion; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; STAT5 Transcription Factor; Tyrosine	2022

Article

Year

The combination of ruxolitinib and Bcl-2/Mcl-1 inhibitors has a synergistic effect on leukemic cells carrying a SPAG9::JAK2 fusion.

Cancer gene therapy, 2022, Volume: 29, Issue:12

Topics: Adaptor Proteins, Signal Transducing; Child; Humans; Interleukin-3; Janus Kinase 2; Myeloid Cell Leukemia Sequence 1 Protein; Oncogene Proteins, Fusion; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; STAT5 Transcription Factor; Tyrosine

2022